Ondine (OBI): LANTERN reads out positive (just about)
LANTERN delivered according to the company. The primary analysis estimated a 40% relative reduction in 30-day surgical site infections and met the trial’s prespecified Bayesian criterion for treatment benefit across 5,188 patients, with no treatment-related serious safety concerns identified. That comfortably clears the double-digit bar I set at initiation. Context matters here. HCA is not […]